诺华制药
130.03
-1.03
-0.79%
NVS
10-10 16:10:00(美东时间)
高
131.87
开
131.82
量
228.96万股
总市值
2517.19亿
低
129.93
换
0.12%
额
3.00亿
市盈TTM
18.44
分时
5日
日K
周K
月K
季K
年K
MA
BOLL
成交量
MACD
KDJ
RSI
WR
BIAS
CCI
PSY
讨论
资讯
公告
资料
财务
相关
成分股
诺华制药(NVS)
10-01 05:15
$诺华制药(NVS)$
6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001171843-25-006196 Act: 34 Size: 78 KB
网页链接
诺华制药(NVS)
09-29 18:55
$诺华制药(NVS)$
SC TO-T Tender offer statement by Third Party Accession Number: 0001104659-25-094086 Size: 4 MB
网页链接
诺华制药(NVS)
09-10 04:15
$诺华制药(NVS)$
SC TO-C Written communication relating to an issuer or third party Accession Number: 0001104659-25-088612 Size: 334 KB
网页链接
诺华制药(NVS)
08-12 04:35
$诺华制药(NVS)$
6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001171843-25-005290 Act: 34 Size: 73 KB
网页链接
诺华制药(NVS)
07-18 04:25
$诺华制药(NVS)$
6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001171843-25-004531 Act: 34 Size: 64 KB
网页链接
诺华制药(NVS)
07-18 04:05
$诺华制药(NVS)$
SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0000861177-25-000006 Act: 34 Size: 9 KB
网页链接
诺华制药(NVS)
07-17 19:25
$诺华制药(NVS)$
6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001370368-25-000012 Act: 34 Size: 12 MB
网页链接
诺华制药(NVS)
06-25 21:25
$诺华制药(NVS)$
SC TO-T/A [Amend] Tender offer statement by Third Party Accession Number: 0001104659-25-062424 Size: 72 KB
网页链接
诺华制药(NVS)
06-23 18:05
$诺华制药(NVS)$
SC TO-T/A [Amend] Tender offer statement by Third Party Accession Number: 0001104659-25-061301 Size: 63 KB
网页链接
诺华制药(NVS)
06-17 18:35
$诺华制药(NVS)$
SC TO-T/A [Amend] Tender offer statement by Third Party Accession Number: 0001104659-25-060052 Size: 24 KB
网页链接
诺华制药(NVS)
06-02 18:15
$诺华制药(NVS)$
6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001171843-25-003556 Act: 34 Size: 64 KB
网页链接
诺华制药(NVS)
05-27 19:05
$诺华制药(NVS)$
SC TO-T Tender offer statement by Third Party Accession Number: 0001104659-25-052701 Size: 6 MB
网页链接
诺华制药(NVS)
05-24 03:45
$诺华制药(NVS)$
144 Report of proposed sale of securities Accession Number: 0001959173-25-003472 Act: 33 Size: 5 KB
网页链接
诺华制药(NVS)
05-02 05:05
$诺华制药(NVS)$
SC TO-C Written communication relating to an issuer or third party Accession Number: 0001104659-25-043563 Size: 39 KB
网页链接
诺华制药(NVS)
05-01 05:05
$诺华制药(NVS)$
SC TO-C Written communication relating to an issuer or third party Accession Number: 0001104659-25-042639 Size: 356 KB
网页链接
诺华制药(NVS)
05-01 02:05
$诺华制药(NVS)$
144 Report of proposed sale of securities Accession Number: 0001959173-25-002749 Act: 33 Size: 4 KB
网页链接
诺华制药(NVS)
04-29 18:05
$诺华制药(NVS)$
6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001370368-25-000010 Act: 34 Size: 1 MB
网页链接
诺华制药(NVS)
04-03 18:05
$诺华制药(NVS)$
6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001171843-25-001979 Act: 34 Size: 74 KB
网页链接
诺华制药(NVS)
03-29 02:14
$诺华制药(NVS)$
6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001171843-25-001805 Act: 34 Size: 65 KB
网页链接
诺华制药(NVS)
01-31 20:25
$诺华制药(NVS)$
6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001370368-25-000008 Act: 34 Size: 15 MB
网页链接
1赞